Cargando…

Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease

BACKGROUND: Aseptic meningitis is a serious adverse reaction to intravenous immunoglobulin (IVIG) therapy. We studied the clinical characteristics of patients with acute Kawasaki disease (KD) who developed IVIG-induced aseptic meningitis. METHODS: A retrospective analysis of the medical records of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemmotsu, Yasushi, Nakayama, Tomotaka, Matsuura, Hiroyuki, Saji, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189389/ https://www.ncbi.nlm.nih.gov/pubmed/21917158 http://dx.doi.org/10.1186/1546-0096-9-28

Ejemplares similares

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011)

Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012)

Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)

Immunoglobulin-induced aseptic meningitis: a case report
por: Graça, Luísa, et al.
Publicado: (2018)

Cerebrospinal fluid changes and clinical features of aseptic meningitis in patients with Kawasaki disease
por: Hu, Fan, et al.
Publicado: (2021)

Intravenous Immunoglobulin-Induced Aseptic Meningitis—A Narrative Review of the Diagnostic Process, Pathogenesis, Preventative Measures and Treatment
por: Kretowska-Grunwald, Anna, et al.
Publicado: (2022)

Value of NSE and S100 Protein of Kawasaki Disease with Aseptic Meningitis in Infant
por: Wang, Jiangtao, et al.
Publicado: (2019)

Immunoglobulin-Induced Aseptic Meningitis in Juvenile Dermatomyositis: A Case Report
por: Chan, Oi Man, et al.
Publicado: (2022)

FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease
por: Okuzaki, Daisuke, et al.
Publicado: (2017)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Clinical Characteristics, Diagnosis, and Management of Aseptic Meningitis Induced by Trimethoprim-Sulfamethoxazole
por: Fan, Zhiqiang, et al.
Publicado: (2023)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
por: Matsuura-Otsuki, Yuki, et al.
Publicado: (2017)

Amoxicillin-Induced Aseptic Meningitis
por: Sousa, Débora, et al.
Publicado: (2020)

Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report
por: Zhang, Yufeng, et al.
Publicado: (2018)

Acute Aseptic Meningitis
por: Gour, K. N.
Publicado: (1943)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Incomplete Kawasaki Disease Associated With Human Herpes Virus-6 Variant B Infection and Aseptic Meningitis
por: Alramadhan, Morouge M., et al.
Publicado: (2020)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Amoxicillin-induced aseptic meningitis: clinical features, diagnosis and management
por: Fan, Zhiqiang, et al.
Publicado: (2023)

Benign Lymphocytic Meningitis: (Acute Aseptic Meningitis)
Publicado: (1940)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data
por: Lam, Jonathan Y., et al.
Publicado: (2023)

Aseptic Meningitis in Kikuchi's Disease
por: Yang, Hyun-Duk, et al.
Publicado: (2005)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

IBUPROFEN-INDUCED ASEPTIC MENINGITIS: A CASE REPORT
por: Pires, Sofia Alexandra Pereira, et al.
Publicado: (2019)

Drug-Induced Aseptic Meningitis Following Spinal Anesthesia
por: Oliveira, Ricardo Paquete, et al.
Publicado: (2019)

Lamotrigine-Induced Lupus With Aseptic Meningitis and Hemophagocytic Lymphohistiocytosis
por: Tran, Dena H, et al.
Publicado: (2022)

Trimethoprim-sulfamethoxazole induced aseptic meningitis case report
por: Pata, Giulia, et al.
Publicado: (2023)

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
por: Ko, Tai-Ming, et al.
Publicado: (2018)

Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4i6gimaaa0q0m4bt7288o4mdd4